Innovation in Immunology and Respiratory Research
Our Immunology and Respiratory disease research combines our proven ability to address unmet medical needs with pioneering patient-centered approaches to accelerate the discovery of breakthrough therapies. Our teams are focused on the discovery and development of new therapeutic concepts that will radically alter the progression of chronic inflammatory and autoimmune diseases.
Our Experience
Scientists in our dedicated immunology and respiratory research and development centers, located in the USA and Germany, have extensive R&D expertise in the discovery and clinical validation of novel mechanisms of action. Together with our academic and industry partners, they are working to offer patients and doctors new therapeutic options to treat chronic inflammatory and fibrotic diseases of the lung, gut and skin.
Our Research Focus
We focus on core scientific themes to arrest the trajectory of chronic inflammatory and fibrotic diseases of the lung, gut and skin:
- Mucosal barrier injury and repair
- Lung repair and regeneration
- Aberrant tissue remodelling
- Novel pathways regulating innate and adaptive immune responses.
Related Content
